• Back to Proguanylin (Guanylate cyclase activator 2A, Guanylate cyclase-activating protein 1, Guanylate cyclase-activating protein I, GCAP-I, GUCA2A, GUCA2)

• Fan X, Wang Y, London R M, Eber S L, Kruse W J, Freeman R H, and Forte L R: Signaling Pathways for Guanylin and Uroguanylin in the digestive, Renal, Central Nervous, Reproductive, and Lymphoid Systems. Endocrinology 138, 4636–4648 (1997)
• Garcia k Ch, Sauvage F J, Strubles M, Henzel W, Reilly D, and Goeddel D V: Processing and Charecterization of Human Proguanylin Expressed in Escherichia coli. The Journal of Biological Chemistry 268, 22397–22401 (1993)
• Hamra F K, Fan X, Krause W J, et al: Prouroguanylin and Proguanylin: Purification from Colon, Structure, and Modulation of Bioactivyity by Proteases. Endocrinology 137, 257–265 (1996)
• Rudolph J A, Hawkins J A, and Cohen M B: Proguanylin secretion and role of negative – feedback inhibition in villous epithelial cell line. Am J Physiol Gastrointest Liver Physiol 238 G695-G702 (2002)
• Lauber T, Neudecker P, Rosch P, and Marx U C: Solution Structure of Human Proguanylin. The Journal of Biological Chemistry 278, 24118–24124 (2003)
• Lauber T, Nourse A, Schulz A, and Marx U C: Native and Recombinant Proguanylin Feature Identical Biophysical Properties and Are Monomeric in Solution. Biochemistry 41, 14602–14612 (2002)
• Sauvage J F, Keshav S, Kuang W-J, Gillett N, Henzel W, and Goeddel D V: Precursor structure, expression, and tissue distribution of human guanylin. Biochemistry 89, 9089–9093 (1992)